Anixa Biosciences
ANIX
ANIX
55 hedge funds and large institutions have $17.3M invested in Anixa Biosciences in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
28% less call options, than puts
Call options by funds: $159K | Put options by funds: $220K
Holders
55
Holding in Top 10
–
Calls
$159K
Puts
$220K
Top Buyers
| 1 | +$1.43M | |
| 2 | +$188K | |
| 3 | +$168K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$142K |
| 5 |
Morgan Stanley
New York
|
+$140K |
Top Sellers
| 1 | -$92.7K | |
| 2 | -$92.6K | |
| 3 | -$79.3K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$68.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$50.7K |